A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment

December 25, 2024 updated by: Yang Bin, The First Affiliated Hospital of Xiamen University
To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery

Study Overview

Study Type

Observational

Enrollment (Estimated)

110

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Fujian
      • Xiamen, Fujian, China, 361000
        • Recruiting
        • First Affiliated Hospital of Xiamen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing breast cancer surgery with general anesthesia in the hospital

Description

Inclusion Criteria:

  1. Patients undergoing breast cancer surgery with general anesthesia in the hospital;
  2. American Society of Anesthesiologists (ASA) classification I-II;
  3. Women aged 18-55 years;
  4. No history of chronic insomnia;
  5. Individuals who have not taken sedative-hypnotic drugs within the past month.

Exclusion Criteria:

  1. Those who do not meet the aforementioned inclusion criteria;
  2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);
  3. A history of sleep disorders and psychiatric history;
  4. Inability to receive thumb-tack needle treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients undergoing breast cancer surgery with general anesthesia in the hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pittsburgh sleep quality index(PSQI)
Time Frame: 1 day or 2 days before anesthesia exposure and 1, 3, and 7 days after anesthesia exposure.
Total scores range from 0 to 21, with higher scores indicating worse sleep quality.
1 day or 2 days before anesthesia exposure and 1, 3, and 7 days after anesthesia exposure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Later Recovery evaluated by QoR-40 questionnaire
Time Frame: QoR-40 score on the third day after surgery
The maximum total score is 200, with higher scores indicating better recovery quality
QoR-40 score on the third day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2024

Primary Completion (Estimated)

October 13, 2026

Study Completion (Estimated)

November 13, 2026

Study Registration Dates

First Submitted

December 18, 2024

First Submitted That Met QC Criteria

December 25, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 25, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FirstAHXiamenU-YB-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Subscribe